Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression
Clinical trial NCT03482882 · COMPLETED
Trial details
- NCT number
- NCT03482882
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-09
- Primary completion
- 2019-07-09
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.